Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS).

Authors:
Soumitra Das
Soumitra Das
Government T. D. Medical College
Vandanam | India
Sumesh T Purushothaman
Sumesh T Purushothaman
Department of Psychiatry
Malathesh Bc
Malathesh Bc
Forensic Psychiatry
Dr Seshadri Sekhar Chatterjee, MBBS, MD, DNB, PDFPsych (NIMHANS)
Dr Seshadri Sekhar Chatterjee, MBBS, MD, DNB, PDFPsych (NIMHANS)
Calcutta Merical College and Hospital
Dr
Kolkata, West Bengal | India
Arjun Kartha
Arjun Kartha
Govt. T. D. Medical College
Akola | India
Varun Rajan
Varun Rajan
Departments of Medical Oncology (Narayanan

Asian J Psychiatr 2017 Dec 8;30:31-32. Epub 2017 Jul 8.

Department of Psychiatry, Government TD Medical College, Alappuzha, Kerala, 688005, India. Electronic address:

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajp.2017.07.006DOI Listing
December 2017
9 Reads

Publication Analysis

Top Keywords

overdose leading
4
malignant syndrome
4
leading neuroleptic
4
neuroleptic malignant
4
asenapine overdose
4
oral asenapine
4
syndrome nms
4
syndrome
1
nms
1
neuroleptic
1
overdose
1
leading
1
oral
1
malignant
1

Similar Publications

[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].

Encephale 2016 Jun 26;42(3):277-80. Epub 2016 Feb 26.

Pôle Santé Publique, Pharmacovigilance, CHU Grenoble-Alpes, 38000 Grenoble, France.

Background: Neuroleptic malignant syndrome (NMS) is an uncommon but potentially fatal adverse effect of neuroleptic drugs. It is commonly characterized by muscular rigidity, fever, altered mental status, and autonomic dysfunction. Emerging of NMS is possible with all neuroleptics, classic and atypical. Read More

View Article
June 2016

[Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].

Fortschr Neurol Psychiatr 1993 Jun;61(6):217-22

Psychiatrische Klinik, Universität Würzburg.

Clozapine is an atypical neuroleptic drug characterised by a striking lack of extrapyramidal side effects. Although these features would seem to make clozapin an unlikely agent for the induction of neuroleptic malignant syndrome (NMS), several putative clozapin-related cases of NMS have recently been reported. A reevaluation of these articles raised some doubts on the causal relationship between clozapin therapy and NMS in most cases. Read More

View Article
June 1993

Increased risk of occurrence of neuroleptic malignant syndrome on combined treatment with lithium and neuroleptic.

Indian J Psychiatry 1997 Jul;39(3):251-5

P. JOHN ALEXANDER, M.D., Associate Professor, Department of Psychiatry, Kasturba Medical College, Manipal 576 119, Karnataka.

Whether there is an increased risk of occurrence of neuroleptic malignant syndrome (NMS) on combined treatment with lithium and neuroleptic is a controversial issue. Patients seen in a general psychiatry unit of a university hospital in India were prospectively screened for NMS over a 2 year period. Diagnosis of NMS was made on operational criteria and the details of treatment at the time of occurrence of NMS were collected systematically. Read More

View Article
July 1997

[Neuroleptic malignant syndrome].

Authors:
E Murak

Psychiatr Pol 1995 May-Jun;29(3):349-58

Ze Specjalistycznego Psychiatrycznego ZOZ w Lodzi.

The Neuroleptic Malignant Syndrome (NMS) is characterized e.g.: by increased muscular tone, fever. Read More

View Article
September 1995